Nando
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its management team and an ambitious expansion of its biotechnological production line. This move is set to position "Nando" not just as a leader in Lithuania but as a formidable player on the international stage.
KAUNAS, LITHUANIA / ACCESSWIRE / May 7, 2024 / In a strategic enhancement of its management team, "Nando" welcomes four seasoned professionals, each bringing a wealth of experience from reputable organizations. Gytis Kubilius, with a solid background in management at "SEB" and "Citadele" banks; Mindaugas Navickas, previously International Sales Manager at "Teltonika Networks"; Arūnas Jusas, former General Manager at "Timac AGRO"; and Giedrė Mockienė, who served as HR Manager at UAB "Yara", are now integral parts of "Nando's" leadership, aiming to spearhead ambitious development projects.
To cater to the surging demand for microbiological alternatives to mineral fertilizers and plant protection products, "Nando" has invested about €3 million in a unique biotechnology line. This investment boosts production volume, enhances productivity, and ensures competitive pricing to meet the escalating market demand. With a technology that is currently patent-pending, "Nando" exports to over 20 countries, including Great Britain, Ukraine, Estonia, Kazakhstan, Latvia, Poland, Romania and beyond.
Justinas Taruška, CEO of "Nando", stated, "Our main goal is to feature a highly automated biotechnological production line. This will not only elevate the agro-biotechnology sector's value in Lithuania but also accelerate sustainable and economically viable agricultural technologies across Europe and other continents." The new production line is renowned for its unique microorganism purification technology, a rarity in the entire Baltic region. It promises an efficient production of stable, high-yield microbiological products in powder form, a technology with limited competition.
The inclusion of new management members, with their extensive international experience, underscores "Nando's" commitment to employee development and its focus on penetrating foreign markets, including Europe, North and South America, Asian and Africa countries. This strategic move coincides with the launch of the new production line for microbiological products.
Founded in 2007, "Nando" stands at the forefront of the biotech industry, developing and manufacturing microbiological products and chemical additives for agriculture. With one of Northern Europe's leading R&D centers and partnerships with global research institutions, "Nando" has introduced over 50 innovative products, vital to the agro, livestock. Currently, the company is intensifying its export activities, with operations spanning over 20 countries in Europe, North and South America, Asian and Africa. The "Nando Group" proudly employs more than 50 professionals dedicated to advancing global biotechnology solutions.
Contact Information:
Milda Gauliene
Marketing specialist
milda@nando.lt
+37066475297
SOURCE: Nando
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide2.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval. Semaglutide: A Proven Therapeutic Leader Semaglutide, developed by Novo Nordisk and marketed under brand names such as Ozempic® and Wegovy®, has revolutionized treatment for Type 2 diabetes and obesity. By mimicking glucagon-like peptide-1 (GLP-1), it enhances insulin secretion, reduces appetite, and slows gastric emptying, offering powerful tools for glycemi
GoodData Launches FlexConnect: Connect to Any Data Source & Transform Data at Run-Time2.12.2024 03:00:00 CET | Press release
SAN FRANCISCO, CA / ACCESSWIRE / December 2, 2024 / Today, GoodData introduces FlexConnect, an advanced component of the GoodData Analytics Lake that redefines data connectivity and computation. FlexConnect enables organizations to: Connect to any data source, including APIs, databases, and ML systems. Execute custom computation logic directly into the data connection using Python, Rust, and other popular languages. Integrate transformed results into GoodData's FlexQuery for further BI computation Render results through any endpoint, GoodData's UI, your UI, or through our APIs and SDKs. "FlexConnect solves a longstanding problem for analytics teams by eliminating the need to wait for vendors to build integrations. With FlexConnect, you can build high-performance connections to a wide range of sources-cloud-based, on-premises, hybrid, SQL, NoSQL, APIs, or machine learning models," said Ryan Dolley, VP of Product Strategy at GoodData. FlexConnect's differentiation lies in its use of Apac
HotelRunner Triumphs as the 'Best Large Technology Supplier' at the Travolution Awards29.11.2024 04:00:00 CET | Press release
HotelRunner, the trailblazing platform for travel and hospitality technologies, has been named the ‘Best Large Technology Supplier' at the Travolution Awards 2024 in the United Kingdom. Selected by the esteemed Travolution Awards jury, this recognition underscores HotelRunner's commitment to innovation and excellence, driving the travel industry forward with data-driven, AI-powered solutions. LONDON, UK / ACCESSWIRE / November 29, 2024 / HotelRunner, the trailblazing platform for travel and hospitality technologies, has been awarded the prestigious "Best Large Technology Supplier" title at the Travolution Awards 2024. The event, held on Nov. 28 in London, celebrated leaders in travel and technology and recognized drivers of innovation and excellence. HotelRunner was selected by a globally respected jury from among six companies competing in the same category, including software companies, tour operator platforms, and SaaS providers. This award recognizes large travel tech companies tha
DEXIS Attends ADF, Showcases Award-Winning Solutions28.11.2024 09:30:00 CET | Press release
QUAKERTOWN, PA / ACCESSWIRE / November 28, 2024 / The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to sensors, CBCT, and imaging software. With an expanded portfolio and ecosystem, DEXIS Solutions is designed to accelerate workflows, increase productivity, and improve the patient experience. "Our technology makes it easy to organize information and execute treatments, which is at the core of what clinicians expect from us," said DEXIS President, Robert Befidi. "We are connecting and standardizing the implant workflow while also constantly evaluating our efforts to ensure we provide deeper patien
SK tes Successfully Included in G-Cloud 14 Framework for Cloud Support for Public Sector Organisations27.11.2024 11:45:00 CET | Press release
LONDON, GB / ACCESSWIRE / November 27, 2024 / SK tes, a leading provider of global IT Asset Disposition (ITAD) and secure data destruction services, is proud to announce its successful inclusion in the G-Cloud 14 Framework for Cloud Support under Lot 3, as awarded by Crown Commercial Services (CCS). This identifies SK tes as a pre-qualified supplier of cloud support services, authorised to work with the UK public sector, having met the rigorous mandatory requirements set forth by the UK Government. G-Cloud 14 is the latest iteration of the UK Government's Procurement Framework, designed to streamline and simplify access to cloud-based computing services for public sector organisations. This framework facilitates government agencies, local authorities, healthcare institutions, educational organisations, and emergency services to seamlessly procure essential cloud services, thus maximising value and efficiency. Lot 3 - Cloud Support specifically encompasses a range of services essential
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom